20.06.2014 12:21:11
|
Kite Pharma Prices IPO At $17 Per Share - Quick Facts
(RTTNews) - Kite Pharma, Inc.(KITE), Friday announced the pricing of its initial public offering of 7.5 million common shares at $17.00 per share. The shares are expected to begin trading on NASDAQ Global Select Market from June 20 under the symbol 'KITE'. The underwriters have been granted a 30-day option to buy up to an additional 1.12 million shares of common stock. Jefferies LLC, Credit Suisse Securities LLC and Cowen and Company LLC are acting as joint book-running managers for the offering. Stifel is acting as co-manager.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Kite Pharma Incmehr Nachrichten
Keine Nachrichten verfügbar. |